2009
DOI: 10.1111/j.1399-0004.2008.01141.x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features of microdeletion 9q22.3 (pat)

Abstract: Congenital anomaly syndromes manifesting overgrowth are rare, and only a small number of recognized or defined conditions are known to be associated with overgrowth. Some of them are related to genomic imprinting as a genetic cause. We report a girl who showed pre- and postnatal overgrowth who was found to have a 2.3-Mb deletion of 9q22.32 involving PTCH1, the gene responsible for Gorlin syndrome (nevoid basal cell carcinoma syndrome), by array-comparative genomic hybridization analysis. Clinical re-evaluation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
32
0

Year Published

2009
2009
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(35 citation statements)
references
References 28 publications
3
32
0
Order By: Relevance
“…aCGH analysis aCGH analysis was performed using a Human Genome CGH Microarray 244 chip (Agilent Technologies, Santa Clara, CA, USA). 25 Genomic copy numbers were visualized using CGH Analytics version 3.5 software (Agilent Technologies).…”
Section: Materials and Methods Subjectsmentioning
confidence: 99%
See 1 more Smart Citation
“…aCGH analysis aCGH analysis was performed using a Human Genome CGH Microarray 244 chip (Agilent Technologies, Santa Clara, CA, USA). 25 Genomic copy numbers were visualized using CGH Analytics version 3.5 software (Agilent Technologies).…”
Section: Materials and Methods Subjectsmentioning
confidence: 99%
“…25 Fifteen BAC clones, RP11-104O19, RP11-1038H1, RP11-198F11, RP11-305G1, RP11-46I8, RP11-457I18, RP11-104N2, RP11-61B20, CTD-2015K4, RP11-542C16, RP11-104H15, RP11-1081A10, RP11-89D11, RP11-1099M24 and RP11-1D5, all of which mapped around 7p13.2p13.1, and RP11-153A23, which mapped on 17q25.3 and used as a marker, were selected from the UCSC Human genome browser, March 2006 (http://genome.ucsc.edu/) ( Table 1).…”
Section: Fluorescence In Situ Hybridization Analysismentioning
confidence: 99%
“…So far 37 patients have been reported as being diagnosed with 9q22 deletions that either matched clinical criteria as regards diagnosis of NBCCS or include PTCH1 within the deleted interval, not including intragenic deletions [Sekhon et al, 1982;Ying et al, 1982;Farrell et al, 1991;Robb et al, 1991;Evans et al, 1993;Kroes et al, 1994;Shimkets et al, 1996;Paoloni-Giacobino et al, 2000;L'Hermine et al, 2002;Olivieri et al, 2003;Haniffa et al, 2004;Midro et al, 2004;Boonen et al, 2005;Cajaiba et al, 2006;Chen et al, 2006;Redon et al, 2006;Fujii et al, 2007;Nowakowska et al, 2007;de Ravel et al, 2009;Musani et al, 2009;Shimojima et al, 2009;Yamamoto et al, 2009;Muller et al, 2012]. Several of the patients presented craniosynostosis, severe obstructive hydrocephalus, macrosomia, and developmental delay, which are not usually seen in NBCCS.…”
Section: Discussionmentioning
confidence: 99%
“…For patient 2, genomic copy number aberrations were analyzed using the Human Genome CGH Microarray 105A chip (Agilent Technologies, Santa Clara, CA) according to methods described elsewhere (Shimojima et al, 2009a). Briefly, 500 ng genomic DNA was extracted from peripheral blood of the patient and the reference individual, using the QIAquick DNA extraction kit (QIAgen, Valencia, CA), and was digested with restriction enzymes.…”
Section: Acgh Analysismentioning
confidence: 99%